Funding opportunities
2,255 live opportunities from Grants.gov, NIH, NSF, and more.
Biomedical & Health× remove
- The role of apelin receptor signaling in lymphatic vesselNational Heart Lung and Blood InstitutePA-24-194 closes 4/30/2028up to $109,696activenih
- Investigating drug use network influences on overdose prevention program utilizationNational Institute on Drug AbusePA-25-302 closes 4/30/2028up to $159,500activenih
- Investigating opioid-induced dopamine rhythms and their role in respiratory suppressionNational Institute on Drug AbusePA-24-194 closes 4/30/2028up to $158,534activenih
- The role of Synaptojanin1 in age-dependent motor declineNational Institute on AgingPA-25-304 closes 4/30/2028up to $431,750activenih
- Development of a synthetic human centromereNational Institute of Biomedical Imaging and BioengineeringPA-25-304 closes 4/30/2028up to $240,000activenih
- Harnessing TLR4 Signaling Pathways in CAR Dendritic Cells to Overcome Tumor Immune ToleranceNational Cancer InstitutePAR-25-139 closes 4/30/2028up to $399,829activenih
- Correction of VCP Disease Pathology with Antisense OligonucleotidesNational Institute on AgingPA-20-195 closes 4/30/2028up to $431,750activenih
- Small molecule inhibitors of the proton-sensing receptor GPR68 for pancreatic cancer therapyNational Cancer InstitutePAR-25-139 closes 4/30/2028up to $411,206activenih
- Countering xylazine damage with natural products targeting cholinergic receptorsNational Institute on Drug AbusePA-20-195 closes 4/30/2028up to $434,005activenih
- Improving Treatment Sensitivity through Syk using Novel Translational Models of Uveal MelanomaNational Cancer InstitutePAR-25-139 closes 4/30/2028up to $415,000activenih
- Plasma protein panels to estimate stroke onset time and differentiate stroke mimics (STROKE-CLOCK study)National Institute of Neurological Disorders and StrokePA-25-150 closes 4/30/2028up to $251,813activenih
- Composite Interferon Signaling Response Biomarker in Aicardi Goutières SyndromeNational Institute of Neurological Disorders and StrokePAR-25-024 closes 4/30/2028up to $775,490activenih
- Lung-targeting immunomodulatory mRNA-lipid nanoparticle systemNational Heart Lung and Blood InstitutePA-25-304 closes 4/30/2028up to $448,250activenih
- Multiomics analysis of benzodiazepine-mediated epigenetic reprogramming in HIV-1 infected hMDMsNational Institute on Drug AbusePAR-25-347 closes 4/30/2028up to $54,000activenih
- Cross-species analysis of regulatory function using synthetic regulatory genomicsNational Human Genome Research InstitutePA-25-304 closes 4/30/2028up to $466,125activenih
- Microbial Risks in Flood-Affected Building Materials: Investigating Contamination, Persistence, and Exposure PathwaysNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 4/30/2028up to $184,592activenih
- Lower Airway Microbial Sulfur Metabolism and Oxidative Stress in Inflammatory Lung DiseaseNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 4/30/2028up to $254,250activenih
- Molecularly-informed polygenic scores for the prediction of response to omega-3 fatty acid supplementationNational Institute of Diabetes and Digestive and Kidney DiseasesPAR-25-091 closes 4/30/2028up to $123,750activenih
- CAGE-Enabled Single-Lineage RNA-Seq for Bacterial PERTURB-Seq and Host-Pathogen Interaction AnalysisNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 4/30/2028up to $295,750activenih
- Investigating lipogenesis mediated resistance to cytotoxic therapy in PDACNational Cancer InstitutePAR-25-139 closes 4/30/2028up to $408,829activenih
- TIGIT+ B cells and transplantation toleranceNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 4/30/2028up to $209,765activenih
- Defining Human Skin Immunity to Culicoides Probing and Oropouche Virus InfectionNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 4/30/2028up to $184,000activenih
- Gut Microbiome Steroid Hormone Metabolism in Inflammatory DiseaseNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 4/30/2028up to $243,824activenih
- Preclinical Development of Oleoylethanolamide as a Medical Countermeasure for Long-Term Neurotoxicity Following Organophosphate ExposureNational Institute of Neurological Disorders and StrokePAR-25-114 closes 4/30/2028up to $468,875activenih
- Genetic Mosaicism and Molecular Mechanisms inHuman Cerebral Cavernous MalformationsNational Institute of Neurological Disorders and StrokePA-25-150 closes 4/30/2028up to $462,151activenih